Merck to Pull Vioxx Off Market over Heart Risks

One of the world's largest drug makers, Merck & Co., announces that it is taking its arthritis drug Vioxx off the market. A study found patients taking high doses of Vioxx had more than three times the risk of heart attack or sudden cardiac death. Hear NPR's Richard Knox.

Comments

 

Please keep your community civil. All comments must follow the NPR.org Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.